Persisting neuropsychiatric symptoms, alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate

HIGHLIGHTS

• who: Sami Ouanes from the We recruited , community-dwelling subjects aged between , and , years in an observational study on biomarkers of cognitive decline and AD conducted at the Department of Psychiatry and the Department of Clinical Neurosciences, University Hospital of Lausanne, SwitzerlandThe study participants with cognitive impairment (n=78) were recruited among outpatients referred to the Memory Clinics, Department of Psychiatry and the Department of Clinical Neurosciences, University Hospital of Lausanne, and who were diagnosed with MCI [18] or mild dementia according to published criteria [18, ] based on neuropsychological and clinical evaluations followed by a consensus conference . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.